In the present study, a novel nine-ERG signature, including CSTB, CEBPB, GBF1, TYR, RAC1, PML, SLC2A1, ICAM1 and NOTCH3, was built to effectively predict the prognosis of patients with melanoma. This evidence concerns the gene ICAM1 and melanoma.